Ibrolipim
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Description: Ibrolipim (NO-1886) attenuates high glucose-induced endothelial dysfunction in... more
Product information "Ibrolipim"
Description: Ibrolipim (NO-1886) attenuates high glucose-induced endothelial dysfunction in cultured human umbilical vein endothelial cells via PI3K/Akt pathway. Target: LPL Receptor. Smiles: CCOP(=O)(Cc1ccc(cc1)C(=O)Nc1ccc(Br)cc1C#N)OCC. References: Chen SG, et al. Ibrolipim increases ABCA1/G1 expression by the LXRalpha signaling pathway in THP-1 macrophage-derived foam cells. Acta Pharmacol Sin. 2010 Oct,31(10):1343-9.
| Keywords: | NO-1886 |
| Supplier: | TargetMol |
| Supplier-Nr: | T7832 |
Properties
| Application: | Targets lipoprotein lipase [EC:3.1.1.34] (LPL) |
| MW: | 451.25 D |
| Formula: | C19H20BrN2O4P |
Database Information
| CAS : | 133208-93-2| Matching products |
| KEGG ID : | K01059 | Matching products |
| Protein Atlas Nr. : | Metabolism |
Handling & Safety
| Storage: | -20°C |
| Shipping: | +4°C (International: +4°C) |
| Signal Word: | Danger |
| GHS Hazard Pictograms: |
|
| H Phrases: | H301 |
| P Phrases: | P264, P270, P321, P330, P301+P310, P405, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed